APLT

APLT

USD

Applied Therapeutics Inc. Common Stock

$0.365+0.000 (0.000%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$0.365

High

$0.385

Low

$0.360

Volume

1.09M

Company Fundamentals

Market Cap

51.7M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

2.18M

Exchange

NGM

Currency

USD

52-Week Range

Low $0.295Current $0.365High $10.624

Related News

GlobeNewswire

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in

View more
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Analyst Upgrades

RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target

RBC Capital analyst Brian Abrahams reiterates Applied Therapeutics with a Sector Perform and maintains $1.5 price target.

View more
RBC Capital Reiterates Sector Perform on Applied Therapeutics, Maintains $1.5 Price Target